The expression of MMP9 has been associated with increased aggressiveness and poor prognosis in patients with non-Hodgkin lymphoma [10], but an influence on prognosis has not been reported in the few studies on cHL [11]–[13]. The gene discussed is MMP9; the disease is non-Hodgkin lymphoma.